Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
Companies
» Company Monitoring Page for Bluebird-Bio
Company Monitoring Page for Bluebird-Bio
latest headlines for company on cafepharma
Ahead of ASCO, Bristol Myers Squibb Announces Results for Three Clinical Trials
BioSpace
Thu, 05/14/20 - 10:56 pm
Tags:
Bristol-Myers Squibb
,
Opdivo
,
Yervoy
,
non-small cell lung cancer
,
ide-cel
,
Multiple Myeloma
,
Bluebird Bio
,
ASCO 2020
Bristol Myers Squibb Receives a 'Refuse to File' Letter for an Experimental Cancer Therapy on a Deadline
Motley Fool
Wed, 05/13/20 - 11:21 am
Tags:
Bristol-Myers Squibb
,
Bluebird Bio
,
refusal to file letter
,
FDA
,
ide-cel
Bristol Myers Squibb Offers bluebird bio a $200 Million Royalty Buyout
Motley Fool
Mon, 05/11/20 - 11:36 pm
Tags:
Bristol-Myers Squibb
,
Celgene
,
M&A
,
Bluebird Bio
Just in time to assure a decision before CVR deadline, Bristol Myers Squibb files NDA for Celgene/bluebird CAR-T
Endpoints
Tue, 03/31/20 - 10:47 am
Tags:
Bristol-Meyers Squibb
,
CAR-T
,
Celgene
,
ide-cel
,
Bluebird Bio
,
liso-cel
,
ozanimod
Bluebird says gene therapy application delayed again, citing disagreement with FDA
BioPharma Dive
Thu, 03/26/20 - 11:57 pm
Tags:
Bluebird Bio
,
LentiGlobin
,
FDA
Why AnaptysBio, bluebird bio, and Exelixis Shares Rebounded Last Friday
Motley Fool
Mon, 03/16/20 - 10:31 am
Tags:
pharma stocks
,
AnaptysBio
,
Bluebird Bio
,
Exelixis
,
COVID-19
Why So Many Biotechs Are Scrambling to Develop a Drug for the Same Rare Disease
Motley Fool
Sun, 02/23/20 - 06:17 pm
Tags:
beta thalassemia
,
rare disease
,
drug development
,
Acceleron
,
Bristol-Myers Squibb
,
Bluebird Bio
,
Sangamo Therapeutics
,
Vertex Pharmaceuticals
,
Editas Medicine
,
Syros Pharmaceuticals
bluebird bio Beats Its Q4 Revenue Target but Misses on EPS
Motley Fool
Wed, 02/19/20 - 09:51 am
Tags:
Bluebird Bio
,
earnings
CAR-T tackles multiple myeloma by using the target CD229 to kill cancer stem cells
Fierce Biotech
Mon, 02/10/20 - 10:11 am
Tags:
CAR-T
,
Multiple Myeloma
,
CD229
,
JNJ
,
Bluebird Bio
5 biopharmas to watch as the decade's last earnings kick off
BioPharma Dive
Wed, 01/22/20 - 11:06 am
Tags:
earnings
,
Novartis
,
Biogen
,
Eli Lilly
,
Global Blood Therapeutics
,
Bluebird Bio
Who are the 10 Most Innovative Biopharma Companies?
BioSpace
Fri, 01/17/20 - 11:41 pm
Tags:
innovation
,
Regeneron
,
Verily
,
Illumina
,
Biogen
,
Bayer
,
Bluebird Bio
,
Novartis
,
GSK
,
Genentech
,
Amgen
LentiGlobin gene therapy for sickle cell on course for filing, says bluebird
Pharmaforum
Wed, 12/11/19 - 09:50 pm
Tags:
LentiGlobin
,
Bluebird Bio
,
sickle cell disease
Myeloma cell therapies, now in pharma hands, move into spotlight
Biopharma Dive
Sat, 12/7/19 - 11:47 pm
Tags:
ASH2019
,
cell therapies
,
Multiple Myeloma
,
Bluebird Bio
,
Bristol-Myers Squibb
,
ide-cel
The Week Ahead In Biotech: ASH 2019 Gets Underway, Biogen's Aducanumab Data And More
Yahoo/Benzinga
Mon, 12/2/19 - 09:42 am
Tags:
ASH2019
,
Roche
,
Bristol-Myers Squibb
,
Acadia Pharmaceuticals
,
Biogen
,
Cassava Sciences
,
Alector
,
GW Pharma
,
Magenta Therapeutics
,
Fortress Biotech
,
Mustang Bio
,
Bluebird Bio
Pfizer, Novartis lead $2 billion spending spree on gene therapy production
Reuters
Wed, 11/27/19 - 12:36 pm
Tags:
gene therapy
,
drug manufacturing
,
Pfizer
,
Novartis
,
Bluebird Bio
,
PTC Therapeutics
,
Krystal Biotech
Bluebird gets European green light for gene therapy production
Biopharma Dive
Fri, 10/25/19 - 10:34 am
Tags:
Bluebird Bio
,
gene therapy
,
Europe
,
Zynteglo
Why Novo Nordisk should buy Uniqure
EP Vantage
Fri, 10/11/19 - 10:31 am
Tags:
Novo Nordisk
,
gene editing
,
hemophilia
,
uniQure
,
Bluebird Bio
Novo taps bluebird bio for gene-editing tech
Fierce Biotech
Wed, 10/9/19 - 09:43 am
Tags:
Novo Nordisk
,
Bluebird Bio
,
R&D
,
gene editing
,
hemophilia
bluebird presents long-term data from CALD gene therapy
Pharmaforum
Fri, 09/20/19 - 09:28 am
Tags:
Bluebird Bio
,
gene therapy
,
cALD
,
Lenti-D
The Week Ahead In Biotech: Novo Nordisk And Merck Await FDA Rulings, 2 IPOs On Deck
Yahoo/Benzinga
Sun, 09/15/19 - 10:05 pm
Tags:
Merck
,
Pifeltro
,
FDA
,
Delstrigo
,
Novo Nordisk
,
oral semaglutide
,
Kodiak Sciences
,
MeiraGTx Holdings
,
IPOs
,
Exagen
,
IGM Biosciences
,
Arrowhead Pharmaceuticals
,
Lexicon Pharmaceuticals
,
Bluebird Bio
,
vTv Therapeutics
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »
last 30 twitter posts
current feelings about your job
job rating
*
1 - I hate my job
2
3
4
5
6
7 - I love my job
Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
please tell us why
*
your industry
*
your job title (optional)
your company
*
published
N/A
published
not published
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
An earthquake would most likely shake a: idea, building, breeze
*
Fill in the blank.